LC - Manchester, England-based molecular diagnostics group - Signs five-year contract extension with Illumina Inc. The ...
Illumina Inc on Wednesday said it swung to a net loss in 2022, as full-year revenue stagnated. The San Diego, Califo ...
Illumina Inc on Tuesday said it is collaborating with AstraZeneca PLC on drug target discovery, with a focus on artif ...
n Diego, California-based biotechnology - Launches a new research test, co-developed with New Jersey, US-based pharmac ...
n Diego, California-based biotechnology company - Announces that Chief Strategy & Corporate Development Officer Joydee ...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 268.29 | 268.29 | 268.29 | 8506 | 268.29 | DE |
4 | 0 | 0 | 268.29 | 268.29 | 268.29 | 3636 | 268.29 | DE |
12 | 0 | 0 | 268.29 | 268.29 | 268.29 | 1632 | 268.29 | DE |
26 | 0 | 0 | 268.29 | 268.29 | 268.29 | 4275 | 268.29 | DE |
52 | 0 | 0 | 268.29 | 268.29 | 268.29 | 5089 | 268.29 | DE |
156 | 0 | 0 | 268.29 | 268.29 | 268.29 | 3061 | 268.29 | DE |
260 | 0 | 0 | 268.29 | 268.29 | 268.29 | 2300 | 268.29 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales